Minimized Extracorporeal Circulation in Coronary Artery Bypass Surgery Is Equivalent to Standard Extracorporeal Circulation in Patients with Reduced Left Ventricular Function

Abstract

Background: Minimized extracorporeal circulation (MECC) is a promising alternative to standard extracorporeal circulation (ECC) and its use is increasing in routine coronary bypass surgery. We analyzed the clinical outcome of patients with reduced left ventricular function who underwent coronary artery bypass surgery with MECC or with standard ECC. Methods: From January 2003 to September 2008, 238 patients with a left ventricular function < 30 % underwent bypass surgery with ECC or MECC. The primary end point of our retrospective observational study was 30-day mortality. Secondary endpoints were the transfusion requirements, as well as intensive care and the in-hospital course. Results: Demographic data, comorbidities and left ventricular function were similar in the study groups. MECC patients had a tendency towards a lower 30-day mortality rate, a better postoperative renal function and reduced ventilation times. Extracorporeal circulation time and postoperative high-dose inotropic support were significantly lower in the MECC group, while the stays in the intensive care unit and in hospital were comparable between the two groups. In our study, age in the ECC group, and previous infarction and New York Heart Association grade IV in the MECC group were preoperative risk factors associated with a higher mortality. Conclusion: Coronary bypass surgery using MECC is feasible and safe for patients with severely impaired left ventricular function. It is a promising alternative to ECC with a low mortality rate and a more favorable postoperative course.

cardiomyopathy - cardiovascular surgery - coronary bypass surgery

References

• 1 Levy J H, Tanaka K A. Inflammatory response to cardiopulmonary bypass.  Ann Thorac Surg. 2003;  75 715-720
• 2 Sergeant P, Wouters P, Meyns B, Bert C, Van Hemelrijck J, Bogaerts C, Sergeant G, Slabbaert K. OPCAB versus early mortality and morbidity: an issue between clinical relevance and statistical significance.  Eur J Cardiothorac Surg. 2004;  25 (5) 779-785
• 3 Gundry S R, Romano M A, Shattuck O H, Razzouk A J, Bailey L L. Seven-year follow-up of coronary artery bypasses performed with and without cardiopulmonary bypass.  J Thorac Cardiovasc Surg. 1998;  115 (6) 1273-1277
• 4 Gummert J F, Funkat A, Beckmann A, Schiller W, Hekmat K, Ernst M, Haverich A. Cardiac surgery in Germany during 2007: a report on behalf of the German Society for Thoracic and Cardiovascular Surgery.  Thorac Cardiovasc Surg. 2008;  56 (6) 328-336
• 5 Fitzgibbon G M, Kafka H P, Leach A J, Keon W J, Hooper G D, Burton J R. Coronary bypass graft fate and patient outcome: angiographic follow-up of 5065 grafts related to survival and reoperation in 1388 patients during 25 years.  J Am Coll Cardiol. 1996;  28 (3) 616-626
• 6 Gundry S R, Romano M A, Shattuck O H, Razzouk A J, Bailey L L. Seven-year follow-up of coronary artery bypasses performed with and without cardiopulmonary bypass.  J Thorac Cardiovasc Surg. 1998;  115 (6) 1273-1277
• 7 Kay G L, Sun G W, Aoki A, Prejean Jr C A. Influence of ejection fraction on hospital mortality, morbidity, and costs for CABG patients.  Ann Thorac Surg. 1995;  60 (6) 1640-1650
• 8 Carr J A, Haithcock B E, Paone G, Bernabei A F, Silverman N A. Long-term outcome after coronary artery bypass grafting in patients with severe left ventricular dysfunction.  Ann Thorac Surg. 2002;  74 (5) 1531-1536
• 9 Philipp A, Foltan M, Thrum A et al. MECC – a minimal ECC system for coronary artery bypass procedures.  J Extra Corpor Technol. 2002;  34 A215
• 10 Wiesenack C, Liebold A, Philipp A et al. Four years experience with a miniaturized extracorporeal circulation system and its influence on clinical outcome.  Artif Organ. 2004;  28 1082-1088
• 11 Liebold A, Khosravi A, Westphal B, Skrabal C, Choi Y H, Stamm C, Kaminski A, Alms A, Birken T, Zurakowski D, Steinhoff G. Effect of closed minimized cardiopulmonary bypass on cerebral tissue oxygenation and microembolization.  J Thorac Cardiovasc Surg. 2006;  131 (2) 268-276
• 12 Fromes Y, Gaillard D, Ponzio O, Chauffert M, Gerhardt M F, Deleuze P, Bical O M. Reduction of the inflammatory response following coronary bypass grafting with total minimal extracorporeal circulation.  Eur J Cardiothorac Surg. 2002;  22 (4) 527-533
• 13 Lenzen M J, Boersma E, Bertrand M E, Maier W, Moris C, Piscione F, Sechtem U, Stahle E, Widimsky P, de Jaegere P, Scholte O P, Reimer W J, Mercado N, Wijns W. for the European Society of Cardiology . Management and outcome of patients with established coronary artery disease: the Euro Heart Survey on Coronary Revascularization.  Eur Heart J. 2005;  26 1169-1179
• 14 Bonett D G, Price R M. Statistical inference for a linear function of medians: confidence intervals, hypothesis testing, and sample size requirements.  Psychol Methods. 2002;  7 (3) 370-383
• 15 Puehler T, Haneya A, Philipp A, Wiebe K, Keyser A, Rupprecht L, Hirt S, Kobuch R, Diez C, Hilker M, Schmid C. Minimal extracorporeal circulation: an alternative for on-pump and off-pump coronary revascularization.  Ann Thorac Surg. 2009;  87 (3) 766-772
• 16 Scott S M, Deupree R H, Sharma G V, Luchi R J. VA study of unstable angina. 10-year results show duration of surgical advantage for patients with impaired ejection fraction.  Circulation. 1994;  90 (5 Pt 2) II120-II123
• 17 Di Carli M F, Maddahi J, Rokhsar S, Schelbert H R, Bianco-Battles D, Brunken R C, Fromm B. Long-term survival of patients with coronary artery disease and left ventricular dysfunction: implications for the role of myocardial viability assessment in management decisions.  J Thorac Cardiovasc Surg. 1998;  116 (6) 997-1004
• 18 Passamani E, Davis K B, Gillespie M J, Killip T. A randomized trial of coronary artery bypass surgery. Survival of patients with a low ejection fraction.  N Engl J Med. 1985;  312 (26) 1665-1671
• 19 Baker D W, Jones R, Hodges J, Massie B M, Konstam M A, Rose E A. Management of heart failure. III. The role of revascularization in the treatment of patients with moderate or severe left ventricular systolic dysfunction.  JAMA. 1994;  272 (19) 1528-1534
• 20 Eagle K A, Guyton R A, Davidoff R et al. American College of Cardiology; American Heart Association. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery).  Circulation. 2004;  110 (14) e340-e437
• 21 Remadi J P, Rakotoarivello Z, Marticho P, Trojette F, Benamar A, Poulain H, Tribouilloy C. Aortic valve replacement with the minimal extracorporeal circulation (Jostra MECC System) versus standard cardiopulmonary bypass: a randomized prospective trial.  J Thorac Cardiovasc Surg. 2004;  128 (3) 436-441
• 22 Hillis G S, Zehr K J, Williams A W, Schaff H V, Orzulak T A, Daly R C, Mullany C J, Rodeheffer R J, Oh J K. Outcome of patients with low ejection fraction undergoing coronary artery bypass grafting: renal function and mortality after 3.8 years.  Circulation. 2006;  114 (Suppl. 1) I414-I419
• 23 Prasser C, Abbady M, Keyl C, Liebold A, Tenderich M, Philipp A, Wiesenack C. Effect of a miniaturized extracorporeal circulation (MECC System) on liver function.  Perfusion. 2007;  22 (4) 245-250
• 24 Remadi J P, Rakotoarivelo Z, Marticho P, Benamar A. Prospective randomized study comparing coronary artery bypass grafting with the new mini-extracorporeal circulation Jostra System or with a standard cardiopulmonary bypass.  Am Heart J. 2006;  151 (1) 198
• 25 Scott B H, Seifert F C, Grimson R. Blood transfusion is associated with increased resource utilisation, morbidity and mortality in cardiac surgery.  Ann Card Anaesth. 2008;  11 (1) 15-19
• 26 van Boven W J, Gerritsen W B, Zanen P, Grutters J C, van Dongen H P, Bernard A, Aarts L P. Pneumoproteins as a lung-specific biomarker of alveolar permeability in conventional on-pump coronary artery bypass graft surgery vs. mini-extracorporeal circuit: a pilot study.  Chest. 2005;  127 (4) 1190-1195
• 27 van Boven W J, Gerritsen W B, Driessen A H, Morshuis W J, Waanders F G, Haas F J, van Dongen E P, Aarts L P. Myocardial oxidative stress, and cell injury comparing three different techniques for coronary artery bypass grafting.  Eur J Cardiothorac Surg. 2008;  34 (5) 969-975
• 28 Filsoufi F, Rahmanian P B, Castillo J G, Chikwe J, Kini A S, Adams D H. Results and predictors of early and late outcome of coronary artery bypass grafting in patients with severely depressed left ventricular function.  Ann Thorac Surg. 2007;  84 (3) 808-816
• 29 Gioia G, Matthai W, Gillin K, Dralle J, Benassi A, Gioia M F, White J. Revascularization in severe left ventricular dysfunction: outcome comparison of drug-eluting stent implantation versus coronary artery by-pass grafting.  Catheter Cardiovasc Interv. 2007;  70 (1) 26-33
• 30 Al-Ruzzeh S, Nakamura K, Athanasiou T, Modine T, George S, Yacoub M, Ilsley C, Amrani M. Does off-pump coronary artery bypass (OPCAB) surgery improve the outcome in high-risk patients: a comparative study of 1398 high-risk patients.  Eur J Cardiothorac Surg. 2003;  23 (1) 50-55
• 31 Hillege H L, Nitsch D, Pfeffer M A, Swedberg K, McMurray J J, Yusuf S, Granger C B, Michelson E L, Ostergren J, Cornel J H, de Zeeuw D, Pocock S, van Veldhuisen D J. Candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) investigators. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure.  Circulation. 2006;  113 (5) 671-678